Gibraltar Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$649K Buy
1,792
+1
+0.1% +$342 0.1% 95
2026
Q1
$630K Sell
1,791
-208
-10% -$74.2K 0.11% 92
2025
Q4
$654K Buy
+1,999
New +$634K 0.11% 90
2016
Q1
Sell
-8,760
Closed -$1.42M 27
2015
Q4
$1.42M Sell
8,760
-355
-4% -$55.8K 1.77% 23
2015
Q3
$1.26M Sell
9,115
-4,197
-32% -$662K 1.56% 28
2015
Q2
$2.04M Sell
13,312
-410
-3% -$65.7K 2.18% 26
2015
Q1
$2.19M Sell
13,722
-4,400
-24% -$693K 2.08% 27
2014
Q4
$2.89M Buy
+18,122
New +$2.82M 2.59% 23

Other funds holding AMGN

Gibraltar Capital Management's AMGN Position: Q2 2026 in Review

Gibraltar Capital Management increased its Amgen (AMGN) stake by 0.06% in Q2 2026, buying an estimated $342 and bringing the position to 1,792 shares worth $649K. The position accounts for 0.1% of the portfolio, ranked #95.

Gibraltar Capital Management first reported a position in AMGN in Q4 2014 and has held it in 8 quarters since. The position peaked at $2.89M in Q4 2014. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gibraltar Capital Management held 1,792 shares of Amgen worth $649K as of Q2 2026.
  • Gibraltar Capital Management bought 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.1% of Gibraltar Capital Management's portfolio in Q2 2026, its #95 holding.
  • Gibraltar Capital Management first reported a position in Amgen in Q4 2014 and has held it in 8 quarters since.
  • Gibraltar Capital Management's Amgen position peaked at $2.89M in Q4 2014.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gibraltar Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.